The Gateway for Cancer Research Offers a Unique Way to Help Fund Clinical

The Gateway for Cancer Analysis Gives a Unique Way to Help Fund Clinical
99 cents of every dollar The Gateway receives goes to fund cancer investigation. The Gateway offers on average $ 28 per patient per day in a Gateway-funded clinical trial. Donations are the life-blood of any non-profit organization and The Gateway is no …
Read a lot more on MarketWatch (press release)

Ovarian cancer drug trials to commence soon
CLINICAL trials for a new Adelaide-developed ovarian cancer drug are expected to begin by the middle of the year. Thebarton drug developer Bionomics has been granted approval to test its BNC-105 drug on women with ovarian cancer.
Read a lot more on Adelaide Now

Everolimus plus exemestane improves bone health in post-menopausal girls with
By ECCO-the European CanCer Organisation, [RxPG] Vienna, Austria: Results from a phase III clinical trial evaluating a new therapy for breast cancer in post-menopausal women show that the mixture of two cancer drugs, everolimus and exemestane, …
Read far more on RxPG NEWS